Skip to main content
. Author manuscript; available in PMC: 2015 May 12.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 May 24;12(4):223–229. doi: 10.1016/j.clml.2012.04.002

Table 1.

Probable Rates of 6-Year MMR and CMR by Level of Adherence to Imatinib33

Response Rate of Adherence
≤ 90% ➢90%
MMR 14% 94% P < .001
CMR 0% 44% P = .002

CMR = complete molecular response; MMR = major molecular response.